IGM Biosciences Inc
NASDAQ:IGMS

Watchlist Manager
IGM Biosciences Inc Logo
IGM Biosciences Inc
NASDAQ:IGMS
Watchlist
Price: 8.89 USD Market Closed
Market Cap: 527.4m USD
Have any thoughts about
IGM Biosciences Inc?
Write Note

Intrinsic Value

IGMS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one IGMS stock under the Base Case scenario is 3.75 USD. Compared to the current market price of 8.89 USD, IGM Biosciences Inc is Overvalued by 58%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IGMS Intrinsic Value
3.75 USD
Overvaluation 58%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
IGM Biosciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IGMS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IGMS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
IGM Biosciences Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about IGM Biosciences Inc

Provide an overview of the primary business activities
of IGM Biosciences Inc.

What unique competitive advantages
does IGM Biosciences Inc hold over its rivals?

What risks and challenges
does IGM Biosciences Inc face in the near future?

Has there been any significant insider trading activity
in IGM Biosciences Inc recently?

Summarize the latest earnings call
of IGM Biosciences Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IGM Biosciences Inc.

Provide P/S
for IGM Biosciences Inc.

Provide P/E
for IGM Biosciences Inc.

Provide P/OCF
for IGM Biosciences Inc.

Provide P/FCFE
for IGM Biosciences Inc.

Provide P/B
for IGM Biosciences Inc.

Provide EV/S
for IGM Biosciences Inc.

Provide EV/GP
for IGM Biosciences Inc.

Provide EV/EBITDA
for IGM Biosciences Inc.

Provide EV/EBIT
for IGM Biosciences Inc.

Provide EV/OCF
for IGM Biosciences Inc.

Provide EV/FCFF
for IGM Biosciences Inc.

Provide EV/IC
for IGM Biosciences Inc.

Show me price targets
for IGM Biosciences Inc made by professional analysts.

What are the Revenue projections
for IGM Biosciences Inc?

How accurate were the past Revenue estimates
for IGM Biosciences Inc?

What are the Net Income projections
for IGM Biosciences Inc?

How accurate were the past Net Income estimates
for IGM Biosciences Inc?

What are the EPS projections
for IGM Biosciences Inc?

How accurate were the past EPS estimates
for IGM Biosciences Inc?

What are the EBIT projections
for IGM Biosciences Inc?

How accurate were the past EBIT estimates
for IGM Biosciences Inc?

Compare the revenue forecasts
for IGM Biosciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IGM Biosciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IGM Biosciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of IGM Biosciences Inc compared to its peers.

Compare the P/E ratios
of IGM Biosciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing IGM Biosciences Inc with its peers.

Analyze the financial leverage
of IGM Biosciences Inc compared to its main competitors.

Show all profitability ratios
for IGM Biosciences Inc.

Provide ROE
for IGM Biosciences Inc.

Provide ROA
for IGM Biosciences Inc.

Provide ROIC
for IGM Biosciences Inc.

Provide ROCE
for IGM Biosciences Inc.

Provide Gross Margin
for IGM Biosciences Inc.

Provide Operating Margin
for IGM Biosciences Inc.

Provide Net Margin
for IGM Biosciences Inc.

Provide FCF Margin
for IGM Biosciences Inc.

Show all solvency ratios
for IGM Biosciences Inc.

Provide D/E Ratio
for IGM Biosciences Inc.

Provide D/A Ratio
for IGM Biosciences Inc.

Provide Interest Coverage Ratio
for IGM Biosciences Inc.

Provide Altman Z-Score Ratio
for IGM Biosciences Inc.

Provide Quick Ratio
for IGM Biosciences Inc.

Provide Current Ratio
for IGM Biosciences Inc.

Provide Cash Ratio
for IGM Biosciences Inc.

What is the historical Revenue growth
over the last 5 years for IGM Biosciences Inc?

What is the historical Net Income growth
over the last 5 years for IGM Biosciences Inc?

What is the current Free Cash Flow
of IGM Biosciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for IGM Biosciences Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
IGM Biosciences Inc

Current Assets 229.6m
Cash & Short-Term Investments 218.8m
Other Current Assets 10.8m
Non-Current Assets 74.9m
PP&E 73.7m
Other Non-Current Assets 1.1m
Current Liabilities 44m
Accounts Payable 3.5m
Accrued Liabilities 37.8m
Other Current Liabilities 2.7m
Non-Current Liabilities 181.6m
Other Non-Current Liabilities 181.6m
Efficiency

Earnings Waterfall
IGM Biosciences Inc

Revenue
2.9m USD
Operating Expenses
-223.6m USD
Operating Income
-220.7m USD
Other Expenses
886k USD
Net Income
-219.8m USD

Free Cash Flow Analysis
IGM Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IGMS Profitability Score
Profitability Due Diligence

IGM Biosciences Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
ROIC is Increasing
Exceptional 1-Year Revenue Growth
Declining ROE
25/100
Profitability
Score

IGM Biosciences Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

IGMS Solvency Score
Solvency Due Diligence

IGM Biosciences Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
54/100
Solvency
Score

IGM Biosciences Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IGMS Price Targets Summary
IGM Biosciences Inc

Wall Street analysts forecast IGMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IGMS is 19.99 USD with a low forecast of 9.09 USD and a high forecast of 50.4 USD.

Lowest
Price Target
9.09 USD
2% Upside
Average
Price Target
19.99 USD
125% Upside
Highest
Price Target
50.4 USD
467% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IGMS?

Click here to dive deeper.

Dividends

IGM Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IGMS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IGMS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

IGM Biosciences Inc Logo
IGM Biosciences Inc

Country

United States of America

Industry

Biotechnology

Market Cap

534.4m USD

Dividend Yield

0%

Description

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. The company is headquartered in Mountain View, California and currently employs 192 full-time employees. The company went IPO on 2019-09-18. The company has developed an IgM antibody technology platform that is particularly well suited for developing T cell engagers, receptor cross-linking agonists and targeted cytokines. Its lead product candidate, IGM-2323, a bispecific T cell engaging IgM antibody targeting CD20 and CD3 proteins, is in an ongoing Phase I clinical trial for the treatment of relapsed/refractory B-cell non-Hodgkin’s lymphoma (NHL) patients. Its second product candidate, IGM-8444, is an IgM antibody targeting Death Receptor 5 (DR5) proteins, which is for the treatment of patients with solid and hematologic malignancies. The Company’s pipeline also includes IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.

Contact

CALIFORNIA
Mountain View
325 E Middlefield Rd
+16509657873.0
igmbio.com

IPO

2019-09-18

Employees

192

Officers

CEO & Director
Ms. Mary Beth Harler M.D.
Chief Financial Officer
Mr. Misbah Tahir
Senior Vice President of Group Operations
Mr. TS Harigopal
Senior VP, Corporate Controller & Principal Accounting Officer
Mr. Steven Weber
Senior Vice President of Legal Affairs
Mr. Paul C. Graffagnino
Chief Human Resources Officer
Ms. Suzette Tauber
Show More
Executive Vice President of Research
Dr. Angus M. Sinclair Ph.D.
Chief Business Officer
Dr. Lisa L. Decker Ph.D.
Executive Vice President of Process Development & Manufacturing
Dr. Marvin S. Peterson Ph.D.
Senior Vice President of Intellectual Property
Dr. Elizabeth Haanes J.D., Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one IGMS stock?

The intrinsic value of one IGMS stock under the Base Case scenario is 3.75 USD.

Is IGMS stock undervalued or overvalued?

Compared to the current market price of 8.89 USD, IGM Biosciences Inc is Overvalued by 58%.

Back to Top